2 studies found for:    22047558 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With Non-neuroblastoma, GD2+ Solid Tumors
Conditions: Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma;   Ewing Sarcoma;   Melanoma
Interventions: Biological: Anti-GD2-CAR engineered T cells;   Drug: AP1903;   Drug: Cyclophosphamide
2 Active, not recruiting CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
Conditions: Acute Lymphoblastic Leukemia;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndrome;   Chronic Myeloid Leukemia
Intervention: Biological: Allodepleted T Cells

Indicates status has not been verified in more than two years